BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 14731311)

  • 1. Safety and efficacy of combined clozapine-lithium pharmacotherapy.
    Bender S; Linka T; Wolstein J; Gehendges S; Paulus HJ; Schall U; Gastpar M
    Int J Neuropsychopharmacol; 2004 Mar; 7(1):59-63. PubMed ID: 14731311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rhabdomyolysis following dose increase of clozapine and combination therapy with lithium.
    Tseng KC; Hwang TJ
    J Clin Psychopharmacol; 2009 Aug; 29(4):398-9. PubMed ID: 19593187
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment outcome with clozapine in tardive dyskinesia, neuroleptic sensitivity, and treatment-resistant psychosis.
    Small JG; Milstein V; Marhenke JD; Hall DD; Kellams JJ
    J Clin Psychiatry; 1987 Jul; 48(7):263-7. PubMed ID: 2885310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Augmentation of clozapine with valproic Acid for clozapine-induced obsessive-compulsive symptoms.
    Zink M; Englisch S; Knopf U; Kuwilsky A; Dressing H
    Pharmacopsychiatry; 2007 Sep; 40(5):202-3. PubMed ID: 17874353
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of lamotrigine in a patient with a clozapine-related seizure.
    Muzyk A; Gala G; Kahn DA
    J Psychiatr Pract; 2010 Mar; 16(2):125-8. PubMed ID: 20511737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Resistant schizophrenia: what chemotherapy?].
    Vanelle JM
    Ann Med Psychol (Paris); 1993 Apr; 151(4):346-51. PubMed ID: 7904434
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of stringent criteria on eligibility for clozapine among public mental health clients.
    Juarez-Reyes MG; Shumway M; Battle C; Bacchetti P; Hansen MS; Hargreaves WA
    Psychiatr Serv; 1995 Aug; 46(8):801-6. PubMed ID: 7583481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clozapine-Valproate Adverse Drug Reactions and the Need for a Clozapine Rechallenge Case File.
    Kanofsky JD; Woesner ME
    Prim Care Companion CNS Disord; 2017 Jan; 19(1):. PubMed ID: 28102977
    [No Abstract]   [Full Text] [Related]  

  • 9. Clozapine treatment of psychosis in patients with tardive dystonia: report of three cases.
    Friedman JH
    Mov Disord; 1994 May; 9(3):321-4. PubMed ID: 7913739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risperidone augmentation of clozapine: a critical review.
    Kontaxakis VP; Ferentinos PP; Havaki-Kontaxaki BJ; Paplos KG; Pappa DA; Christodoulou GN
    Eur Arch Psychiatry Clin Neurosci; 2006 Sep; 256(6):350-5. PubMed ID: 16900439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clozapine for treatment-resistant schizophrenia: National Institute of Clinical Excellence (NICE) guidance in the real world.
    Mortimer AM; Singh P; Shepherd CJ; Puthiryackal J
    Clin Schizophr Relat Psychoses; 2010 Apr; 4(1):49-55. PubMed ID: 20643629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of lamotrigine to augment clozapine in patients with resistant schizophrenia and comorbid alcohol dependence: a potent anti-craving effect?
    Kalyoncu A; Mirsal H; Pektas O; Unsalan N; Tan D; Beyazyürek M
    J Psychopharmacol; 2005 May; 19(3):301-5. PubMed ID: 15888516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clozapine-induced tardive dyskinesia: a case report.
    Ertugrul A; Demir B
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 May; 29(4):633-5. PubMed ID: 15866369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term treatment of mood disorders in schizophrenia.
    Azorin JM
    Acta Psychiatr Scand Suppl; 1995; 388():20-3. PubMed ID: 7541599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerability and efficacy of clozapine combined with lithium in schizophrenia and schizoaffective disorder.
    Small JG; Klapper MH; Malloy FW; Steadman TM
    J Clin Psychopharmacol; 2003 Jun; 23(3):223-8. PubMed ID: 12826983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clozapine: current status and role in the pharmacotherapy of schizophrenia.
    Remington GJ; Addington D; Collins EJ; Jones BD; Lalonde P; MacCrimmon DJ; MacEwan GW
    Can J Psychiatry; 1996 Apr; 41(3):161-6. PubMed ID: 8722645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lithium and clozapine-induced neutropenia/agranulocytosis.
    Blier P; Slater S; Measham T; Koch M; Wiviott G
    Int Clin Psychopharmacol; 1998 May; 13(3):137-40. PubMed ID: 9690982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benefits of combining aripiprazole to clozapine: three case reports.
    Rocha FL; Hara C
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1167-9. PubMed ID: 16647796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of atypical antipsychotics in Charles Perrens psychiatric hospital (Bordeaux) analysis of prescribing practices for Amisulpride, Clozapine, Olanzapine and Risperidone].
    Bret P; Bonnet F; Bret MC; Jaffré A
    Encephale; 2002; 28(4):329-42. PubMed ID: 12232542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risperidone augmentation of clozapine.
    McCarthy RH; Terkelsen KG
    Pharmacopsychiatry; 1995 Mar; 28(2):61-3. PubMed ID: 7542786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.